Boehringer Ingelheim GmbH
Postdoc: Hybrid Evidence Synthesis for HTA & Market Access
Boehringer Ingelheim GmbH, New Bremen, Ohio, United States
A global pharmaceutical company is seeking a Postdoc for Evidence Synthesis in Health Technology Assessment. The ideal candidate should hold a PhD in Statistics or a related field and have expertise in evidence synthesis methods. The role involves collaborating with teams to enhance statistical methods, developing toolkits for evidence integration, and providing training. A hybrid work setup is offered. Interested candidates should apply in English by January 29th, 2026 to ensure consideration.
#J-18808-Ljbffr